Log in to save to my catalogue

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with con...

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with con...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3156064259

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

About this item

Full title

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Publisher

Tirgu-Mures: De Gruyter Poland

Journal title

Acta Medica Marisiensis, 2023-03, Vol.69 (1), p.11-16

Language

English

Formats

Publication information

Publisher

Tirgu-Mures: De Gruyter Poland

More information

Scope and Contents

Contents

Objective: This review aims to make a brief overview of blood biomarkers’ clinical decision limits, possibly aiding in outcome prediction in all-aged Tetralogy of Fallot patients. Potentially, these biomarkers could also assist in necessity and timing of pulmonary valve replacement.Methods: Studies with all-aged patients with Tetralogy or Pentalogy...

Alternative Titles

Full title

Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3156064259

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3156064259

Other Identifiers

ISSN

2068-3324

E-ISSN

2247-6113

DOI

10.2478/amma-2023-0009

How to access this item